Efficacy and Safety of Moxonidine in Indian Patients

Phase 3

Completed

• Conditions: Hypertension

• Registration Number: NCT00160277
• Lead Sponsor: Solvay Pharmaceuticals

Brief Summary

The purpose of this study is to demonstrate efficacy and safety of Moxonidine in Indian subjects.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-07
• Study First Submitted: 2005-09-09
• Study First Submitted QC: 2005-09-09
• Study First Posted: 2005-09-12
• Status Verified: 2009-01
• Last Update Submitted: 2009-01-29
• Last Update Posted: 2009-01-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Hypertension

Exclusion Criteria

Severe concomitant diseases, CHF, secondary hypertension, severe hypertension, significant hepatic disease, unstable angina

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Systolic blood pressure reduction

Secondary Outcome Measures

Name	Time	Method
Piggy-back pharmacoeconomic evaluation; Safety and tolerability

Trial Locations

Locations (3)

Site 3; 🇮🇳 New Delhi, India

Site 1; 🇮🇳 Jubillee Hills Hyderabad, India

Site 2; 🇮🇳 Mangalore, India